Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 8

Results: 20

Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 2029, doi. 10.1007/s00262-021-03139-4

By:

Femel, Julia;
van Hooren, Luuk;
Herre, Melanie;
Cedervall, Jessica;
Saupe, Falk;
Huijbers, Elisabeth J. M.;
Verboogen, Danielle R. J.;
Reichel, Matthias;
Thijssen, Victor L.;
Griffioen, Arjan W.;
Hellman, Lars;
Dimberg, Anna;
Olsson, Anna-Karin

Publication type:

Article

Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 2007, doi. 10.1007/s00262-021-03136-7

By:

He, Liuyang;
Bai, Yu;
Xia, Lei;
Pan, Jie;
Sun, Xiao;
Zhu, Zhichao;
Ding, Jun;
Qi, Chunjian;
Tang, Cui

Publication type:

Article

Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16<sup>+</sup> cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1975, doi. 10.1007/s00262-021-03134-9

By:

Salomon, Nadja;
Selmi, Abderaouf;
Grunwitz, Christian;
Kong, Anthony;
Stanganello, Eliana;
Neumaier, Jennifer;
Petschenka, Jutta;
Diken, Mustafa;
Kreiter, Sebastian;
Türeci, Özlem;
Sahin, Ugur;
Vascotto, Fulvia

Publication type:

Article

Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 2051, doi. 10.1007/s00262-021-03133-w

By:

Strobel, Sophia B.;
Machiraju, Devayani;
Kälber, Katharina A.;
Hassel, Jessica C.

Publication type:

Article

Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1949, doi. 10.1007/s00262-021-03132-x

By:

Czarnecka, Anna Małgorzata;
Sobczuk, Paweł;
Rogala, Paweł;
Świtaj, Tomasz;
Placzke, Joanna;
Kozak, Katarzyna;
Mariuk-Jarema, Anna;
Spałek, Mateusz;
Dudzisz-Śledź, Monika;
Teterycz, Paweł;
Borkowska, Aneta;
Rutkowski, Piotr

Publication type:

Article

Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1813, doi. 10.1007/s00262-021-03131-y

By:

Njonkou, Rosy;
Jackson, Christopher M.;
Woodworth, Graeme F.;
Hersh, David S.

Publication type:

Article

Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1959, doi. 10.1007/s00262-021-03129-6

By:

Liao, Fei;
Zhang, Jing;
Hu, Yangyang;
Najafabadi, Alireza Hassani;
Moon, James J.;
Wicha, Max S.;
Kaspo, Bashir;
Whitfield, Joel;
Chang, Alfred E.;
Li, Qiao

Publication type:

Article

Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1795, doi. 10.1007/s00262-021-03128-7

By:

Cheung, Yee-Ming Melody;
Wang, Wei;
McGregor, Bradley;
Hamnvik, Ole-Petter Riksfjord

Publication type:

Article

Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1937, doi. 10.1007/s00262-021-03127-8

By:

Waidhauser, Johanna;
Nerlinger, Pia;
Arndt, Tim Tobias;
Schiele, Stefan;
Sommer, Florian;
Wolf, Sebastian;
Löhr, Phillip;
Eser, Stefan;
Müller, Gernot;
Claus, Rainer;
Märkl, Bruno;
Rank, Andreas

Publication type:

Article

Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1989, doi. 10.1007/s00262-021-03126-9

By:

Cluff, Emily;
Magdaleno, Carina C.;
Fernandez, Emyly;
House, Trenton;
Swaminathan, Srividya;
Varadaraj, Archana;
Rajasekaran, Narendiran

Publication type:

Article

Functional virus-specific memory T cells survey glioblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1863, doi. 10.1007/s00262-021-03125-w

By:

Ning, Jianfang;
Gavil, Noah V.;
Wu, Shaoping;
Wijeyesinghe, Sathi;
Weyu, Eyob;
Ma, Jun;
Li, Ming;
Grigore, Florina-Nicoleta;
Dhawan, Sanjay;
Skorput, Alexander G. J.;
Musial, Shawn C.;
Chen, Clark C.;
Masopust, David;
Rosato, Pamela C.

Publication type:

Article

Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1877, doi. 10.1007/s00262-021-03124-x

By:

Okada, Ryuhei;
Kato, Takuya;
Furusawa, Aki;
Inagaki, Fuyuki;
Wakiyama, Hiroaki;
Fujimura, Daiki;
Okuyama, Shuhei;
Furumoto, Hideyuki;
Fukushima, Hiroshi;
Choyke, Peter L.;
Kobayashi, Hisataka

Publication type:

Article

Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1923, doi. 10.1007/s00262-021-03123-y

By:

Xu, Wenhao;
Ma, Chunguang;
Liu, Wangrui;
Anwaier, Aihetaimujiang;
Tian, Xi;
Shi, Guohai;
Qu, Yuanyuan;
Wei, Shiyin;
Zhang, Hailiang;
Ye, Dingwei

Publication type:

Article

A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 2041, doi. 10.1007/s00262-021-03122-z

By:

Kiyohara, Eiji;
Tanemura, Atsushi;
Sakura, Kazuma;
Nakajima, Toshihiro;
Myoui, Akira;
Yamazaki, Naoya;
Kiyohara, Yoshio;
Katayama, Ichiro;
Fujimoto, Manabu;
Kaneda, Yasufumi

Publication type:

Article

A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1889, doi. 10.1007/s00262-021-03121-0

By:

Zuo, Bangyou;
Yang, Xiaobo;
Yang, Xu;
Bian, Jin;
Long, Junyu;
Wang, Dongxu;
Ning, Cong;
Wang, Yanyu;
Xun, Ziyu;
Wang, Yunchao;
Lu, Xin;
Mao, Yilei;
Sang, Xinting;
Zhao, Haitao

Publication type:

Article

Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1851, doi. 10.1007/s00262-021-03119-8

By:

Gaignage, Mélanie;
Zhang, Xuhao;
Stockis, Julie;
Dedobbeleer, Olivier;
Michiels, Camille;
Cochez, Perrine;
Dumoutier, Laure;
Coulie, Pierre G.;
Lucas, Sophie

Publication type:

Article

Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1909, doi. 10.1007/s00262-021-03111-2

By:

Roversi, Fernanda Marconi;
Bueno, Maura Lima Pereira;
da Silva, Juliete Aparecida Francisco;
Assis-Mendonça, Guilherme Rossi;
Torello, Cristiane Okuda;
Shiraishi, Rodrigo Nato;
Pericole, Fernando Viera;
Ferro, Karla Priscila;
Duarte, Adriana Santos Silva;
Rego, Eduardo Magalhães;
Saad, Sara Teresinha Olalla

Publication type:

Article

The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1823, doi. 10.1007/s00262-021-03107-y

By:

Zamora Atenza, Carlos;
Anguera, Geòrgia;
Riudavets Melià, Mariona;
Alserawan De Lamo, Letícia;
Sullivan, Ivana;
Barba Joaquin, Andrés;
Serra Lopez, Jorgina;
Ortiz, M. Angels;
Mulet, Maria;
Vidal, Sílvia;
Majem, Margarita

Publication type:

Article

Combination immunotherapy including OncoVEX<sup>mGMCSF</sup> creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1837, doi. 10.1007/s00262-021-03088-y

By:

Gartrell, Robyn D.;
Blake, Zoë;
Rizk, Emanuelle M.;
Perez-Lorenzo, Rolando;
Weisberg, Stuart P.;
Simoes, Ines;
Esancy, Camden;
Fu, Yichun;
Davari, Danielle R.;
Barker, Luke;
Finkel, Grace;
Mondal, Manas;
Minns, Hanna E.;
Wang, Samuel W.;
Fullerton, Benjamin T.;
Lozano, Francisco;
Chiuzan, Codruta;
Horst, Basil;
Saenger, Yvonne M.

Publication type:

Article

Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1897, doi. 10.1007/s00262-021-03102-3

By:

Gong, Jifang;
Cao, Junning;
Zhang, Qingyuan;
Xu, Nong;
Zhao, Yanqiu;
Xing, Baocai;
Miao, Zhanhui;
Wu, Yilong;
Pan, Hongming;
Gao, Quanli;
Li, Xingya;
Liu, Baorui;
Li, Wei;
Pei, Zhidong;
Xia, Hongqiang;
Qi, Qinzhou;
Dai, Hangjun;
Shi, Qingmei;
Yang, Jianxin;
Li, Jin

Publication type:

Article